OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 2, 2023

Rhea-AI Summary

OrthoPediatrics Corp. (NASDAQ: KIDS) announced the upcoming release of its first quarter 2023 financial results on May 1, 2023, after market close. A conference call will be held on May 2, 2023, at 8:00 a.m. ET to discuss these results. The company, founded in 2006, specializes in pediatric orthopedics and currently offers 47 surgical systems targeting trauma, deformity, scoliosis, and sports medicine. OrthoPediatrics operates globally, distributing its products in the U.S. and over 70 additional countries. Investors can access the conference call via a live and archived webcast on the company's website.

Positive

• Scheduled financial results announcement on May 1, 2023.
• Conference call to discuss Q1 results on May 2, 2023, indicating transparency and investor engagement.

Negative

• None.

WARSAW, Ind., April 17, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2023 financial results on Monday, May 1, 2023, after the market closes. OrthoPediatrics will host a conference call on Tuesday, May 2, 2023, at 8:00 a.m. ET to discuss the results.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 47 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact:
Philip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

FAQ

When will OrthoPediatrics release its Q1 2023 financial results?

OrthoPediatrics will release its Q1 2023 financial results on May 1, 2023, after market close.

What time is the conference call for OrthoPediatrics' Q1 2023 earnings?

The conference call is scheduled for May 2, 2023, at 8:00 a.m. ET.

How can I listen to the OrthoPediatrics conference call?

Investors can listen to the conference call via a live and archived webcast on the OrthoPediatrics website.

What type of products does OrthoPediatrics offer?

OrthoPediatrics offers 47 surgical systems focused on pediatric orthopedic markets including trauma, deformity, scoliosis, and sports medicine.